Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Cognitive Computing and Artificial Intelligence Systems Market in...
The global market for cognitive computing and AI systems in healthcare should reach $16.1 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 45.9% for the period of 2017 to 2022.
Latin America Retail Industry Profile and Directory
Latin American (LATAM) retail market will grow from $263.4 billion in 2017 to nearly $297.9 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
Biochip: Global Markets to 2023
The global biochips market should reach $27.3 billion by 2023 from $6.9 billion in 2018 at a compound annual growth rate (CAGR) of 31.8% for the period of 2018-2023.
Atrial Fibrillation: Technologies and Global Markets
The global market for atrial fibrillation devices should grow from $4.1 billion in 2018 to $7.8 billion by 2023 at a compound annual growth rate (CAGR) of 13.6% for the period of 2018-2023.
Blood Testing: Technologies and Global Markets
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Checkpoint Inhibitors: Global Markets
The global checkpoint inhibitors market should reach $29.3 billion by 2023 from $14.9 billion in 2018 at a compound annual growth rate (CAGR) of 14.4% for the period of 2018-2023.
Global Viral Vector Manufacturing Markets and Technologies Throug...
The global market for viral vector vaccine manufacturing is expected to increase from $22.9 million in 2017 to nearly $51.2 million in 2022 at a compound annual growth rate (CAGR) of 17.5% for 2017-2022.
Technologies for Long-term Care and Home Healthcare: Global Marke...
The global market for elder care technologies should grow from $5.7 billion in 2017 to $13.6 billion by 2022 at a compound annual growth rate (CAGR) of 19.2% from 2017 through 2022.
Chromatography: A BCC Research Outlook
The global market for chromatography reagents should grow from $10.0 billion in 2018 to $14.2 billion by 2023 at a compound annual growth rate (CAGR) of 7.4% from 2018 through 2023.
Medical Ultrasound Devices: Technologies and Global Markets
The global market for medical ultrasound devices will grow from $6.7 billion in 2018 to $7.8 billion by 2023 with a compound annual growth rate (CAGR) of 3.0% for the period of 2018-2023.
Antipsychotic Drugs: Technologies and Global Markets
The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.
Mixed Tocopherols: Technologies and Global Markets
The global mixed tocopherols market should reach $5.4 billion by 2023 from $4.3 billion in 2018 at a compound annual growth rate (CAGR) of 4.7% for the period of 2018-2023.
Lysosomal Disease Treatments: Technologies and Global Markets
The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Dental Implants: Global Markets to 2023
The global market for dental implants reached $3.6 billion in 2018 and should reach nearly $5.0 billion by 2023, at a compound annual growth rate (CAGR) of 6.5% for the period of 2018-2023.
Medical Tourism: Market Outlook and Trends
Medical tourism is considered the direct impact of the globalization of healthcare and it has the potential for strong growth globally. It has presented new opportunities and benefits to individuals looking for medical treatment abroad. The medical tourism industry has presented countries with low cost and high-income possibilities leading the countries to plan and develop this section of the tourism industry. Affordability and accessibility of healthcare services offered by medical tourism has spiked the market growth.
Assistive Devices for Special Needs: Technologies and Global Mark...
The global market for assistive devices for special needs reached nearly $15.9 billion in 2018 and should reach $20.1 billion by 2023, at a compound annual growth rate (CAGR) of 4.9% for the period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
The Probiotics Market: Ingredients, Supplements, Foods
The global market for probiotics should grow from $39.2 billion in 2017 to $57.2 billion in 2022, growing at a compound annual growth rate (CAGR) of 7.8% from 2017 through 2022.
Biosensors and Nanosensors: Global Markets and Technologies
The global market for biosensors and nanosensors should grow from $21.1 billion in 2018 to reach $31.9 billion by 2023, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period of 2018-2023.
Endovascular Treatment Devices: EVAR and TEVAR Emphasis
The global market for endovascular treatment devices reached $2.0 billion in 2017 and should reach nearly $2.8 billion by 2022, at a compound annual growth rate (CAGR) of 7.3% from 2017 to 2022.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Drugs and Diagnostics for Hematological Disorders: Global Markets
This report provides an overview of the current and potential global market for hematological disorders and its treatments and testing technologies.
Cell Therapy Biomanufacturing: Global Markets
This report provides an overview of the global markets for cell therapy biomanufacturing.
Wearable Medical Devices: Technologies and Global Markets
This report provides an in-depth analysis of the medical devices industry and its competitive landscape.
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
This report provides a comprehensive analysis on technologies and applications of SNP genotyping, along with a critical perspective of the industry’s trends, future potential, and direction.
In Vitro Diagnostics (IVD) Quality Controls: Global Market
The report provides information on the latest developments in the quality control test, what are the latest technologies being used, and how the efforts are made by the key players introducing the products to markets.
Theranostics: Global Markets
This report will focus on theranotics, based products and types. Equipment as well as therapeutic agents. These reports include the approved drugs which are available on the market and research-based products.
Artificial Intelligence (AI) in Lifesciences Market
This report provides an overview of the market size of global artificial intelligence (AI) in the life sciences market.
Global Live Cell Imaging Market
This report focuses on the products and services offered in the live cell imaging market.
Global Single-cell Technologies Market
This report provides an overview of the global single-cell technologies market.
Gene Editing Therapeutics Market
This study encompasses an investigation of the gene editing therapeutics market. BCC Research analyzes gene editing therapeutics based on technology type, therapeutic area, and approach.
Global Multiomics Market
This report provides a comprehensive analysis of products, types, platforms, applications, and end-users of multiomics, along with a critical perspective of the industry's trends, future potential, and direction.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
This report examines the current and forecasted market potential of radiopharmaceuticals and therapeutics. It offers a detailed analysis of the technological advancement, competitive environment, market background, drivers and restraints, and market growth trends.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The goal of the report is to examine market opportunities for the microelectronic medical implant industry and the technologies that make possible the more advanced products that are rapidly coming into being.
Global Markets for Drug-Device Combinations
This report provides a detailed understanding of the global drug-device combination products market.
Global Automated and Closed Cell Therapy Market
This report provides a detailed market, technology, and industry analyses to help readers quantify and qualify the market for the closed and automated cell therapy market.
Medical Devices: Technologies and Global Markets
This report provides an in-depth analysis of the medical device technology market, including market estimations and trends. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
This report provides an overview of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market.
Drug Discovery Technologies
This report will provide detailed exposure to the drug discovery technologies, its current and future market potential and a detailed analysis of the competitive environment.
AI in Clinical and Molecular Diagnostics Market
This report explains critical trends in AI in clinical and molecular diagnostic industry. The report examines market determinants that serve as driving or inhibiting factors, offering valuable insights to stakeholders and potential entrants.
Life Science Tools and Reagents: Global Market Outlook
This report explores the current and future market potential for life science tools and reagents, its competitive environment, regulatory scenario, and market trends, including projections through 2029 and key players
Point of Care Diagnostics: Technologies and Global Markets
This report explores the current and future market potential for point of care diagnostics, its competitive environment, regulatory scenario, and market trends, including projections through 2029 and key players